MDT: Analysis & Opinions

  1. MDT Progresses with CoreValve Trial - Analyst Blog

    July 20, 2012
    Leading medical devices player, Medtronic (MDT), has enrolled the first patient in the Surgical Replacement and ...
  2. Greatbatch to Build R&D Centre - Analyst Blog

    July 20, 2012
    Medical technologies company, Greatbatch Inc. (GB) recently announced that it will set up an Active Implantable ...
  3. Mixed 2Q for St. Jude, Trims Outlook - Analyst Blog

    July 18, 2012
    Medical devices major, St. Jude Medical, Inc.'s (STJ) second quarter 2012 adjusted earnings of 88 cents per share ...
  4. Greatbatch to Relocate Ortho Unit - Analyst Blog

    July 05, 2012
    Medical technology company, Greatbatch Inc. (GB) recently proposed to relocate Greatbatch Medical's orthopedics ...
  5. BSX Progresses on Prevail Trial - Analyst Blog

    July 03, 2012
    With its core segments of stents and defibrillators struggling, leading medical devices player Boston Scientific ...
  6. Zimmer Expands US Spinal Portfolio - Analyst Blog

    June 27, 2012
    Zimmer Holdings (ZMH) has strengthened its spinal portfolio in the US with the introduction of TM Ardis interbody ...
  7. Obamacare's Future in the Balance - Analyst Blog

    June 27, 2012
    The country is awaiting a major event later this week with the Supreme Court scheduled to deliver a decision on the ...
  8. Cyberonics Reaffirmed at Neutral - Analyst Blog

    June 25, 2012
    We have reiterated our Neutral recommendation on Cyberonics Inc. (CYBX) with a target price of $46.00, following our ...
  9. MDT Stent Chosen for FDA Pilot Study - Analyst Blog

    June 25, 2012
    Last week, leading medical devices player, Medtronic (MDT) announced that the US Food and Drug Administration ...
  10. Medtronic Hikes Dividend - Analyst Blog

    June 22, 2012
    Leading medical device player, Medtronic (MDT) announced a 7.2% increase in its cash dividend for fiscal 2013. With ...
  11. Integra's New PIP Fixation Device - Analyst Blog

    June 22, 2012
    Medical products company, Integra LifeSciences Holdings Corporation (IART) unveiled its latest device for fixing ...
  12. Balanced View on Medtronic - Analyst Blog

    June 21, 2012
    We reiterate our Neutral recommendation on Medtronic (MDT) with a target price of $40.00. The company's revenues ...
  13. St. Jude's AVP4 Gets FDA Approval - Analyst Blog

    June 19, 2012
    Leading medical devices company, St. Jude Medical Inc. (STJ), has received the Food and Drug Administration's ...
  14. MedTech Industry Stock Outlook - June 2012 - Industry ...

    June 18, 2012
    Over the recent past, medical technology (MedTech) players have faced the brunt of exigent economic conditions and a ...
  15. MedTech Industry Stock Outlook - June 2012 - Zacks ...

    June 18, 2012
    Over the recent past, medical technology (MedTech) players have faced the brunt of exigent economic conditions and a ...
  16. DexCom Wins CE Mark - Analyst Blog

    June 15, 2012
    DexCom (DXCM), a player in the glucose monitoring market, recently reported that it received a CE Mark for its 4th ...
  17. BSX Sees Prospects in Endoscopy - Analyst Blog

    June 13, 2012
    Earlier this week Boston Scientific Corporation (BSX) reviewed future prospects of its endoscopy business. This ...
  18. New Licensing Deal for Cyberonics - Analyst Blog

    June 12, 2012
    Leading neuromodulation company, Cyberonics Inc. (CYBX) recently entered into an exclusive technology licensing ...
  19. Edwards' GLX Gain IDE Approval - Analyst Blog

    June 12, 2012
    Edwards Lifesciences Corporation (EW) has received conditional Investigational Device Exemption ("IDE") approval ...
  20. DexCom Retained at Neutral - Analyst Blog

    June 11, 2012
    We remain Neutral on DexCom (DXCM). Its first-quarter 2012 loss per share of 21 cents exceeded the Zacks Consensus ...
Marketplace
Trading Center